-
Sector Analysis
Health and Beauty Retailing in Netherlands – Market Shares, Summary and Forecast to 2022
"Health & Beauty Retailing in the Netherlands, Market Shares, Summary and Forecasts to 2022", provides data for historic and forecast retail sales, and also includes information on the business environment and country risk related to the Netherlands retail environment. In addition, it analyzes the key consumer trends influencing the Netherlands health and beauty industry. Dutch health & beauty sales are forecast to grow at 2.6% CAGR to reach €13.8 billion by 2022. Spending on the health segment is more than...
-
Sector Analysis
Health and Beauty Retailing in Belgium – Market Shares, Summary and Forecast to 2022
"Health & beauty Retailing in Belgium, Market Shares, Summary and Forecasts to 2022", provides data for historic and forecast retail sales, and also includes information on the business environment and country risk related to Belgium retail environment. In addition, it analyzes the key consumer trends influencing Belgium health and beauty industry. Health & beauty is the fourth largest sector in the Belgian retail industry and contributed 9% to total retail sales in 2017. What else does this report offer? -...
-
Sector Analysis
Global Polyethylene Industry Outlook to 2022 – Capacity and Capital Expenditure Forecasts with Details of All Active and Planned Plants
Global Polyethylene capacity is expected to experience considerable growth over the next nine years from around 100 mtpa in 2017 to more than 140 mtpa by 2026. More than 100 planned and announced Polyethylene projects are expected to come online, primarily in the Middle East and Asia over the next nine years. Sibur Holding, Badlands Ngls LLC and Gazprom are the top three companies in terms of planned capacity additions during the outlook period.
-
Sector Analysis
Health and Beauty Retailing in Netherlands – Market Shares, Summary and Forecast to 2021
"Health & Beauty Retailing in Netherlands, Market Shares, Summary & Forecasts to 2021", provides data for historic and forecast retail sales, and also includes information on the business environment and country risk related to Netherlands retail environment. In addition, it analyzes the key consumer trends influencing Netherlands health and beauty industry. As the Dutch economy recovers from the impact of the European debt crisis, retail sales are expected to grow steady at a CAGR of 2.1%, during 2016-2021. In 2016,...
-
Sector Analysis
Non-Small Cell Lung Cancer (NSCLC) – US Drug Forecast and Market Analysis to 2025
Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung cancer incident cases, approximately 85% are the non-small cell lung cancer (NSCLC) subtype. NSCLC patients are usually diagnosed in the later stages of the disease, with poor prognosis. Historically, treatment options for advanced-stage NSCLC patients have been dominated by chemotherapy. However, the launch of targeted therapies such as Iressa (gefitinib) in 2003, Tarceva (erlotinib) in 2004, and Xalkori (crizotinib) in 2011, has shifted...
-
Sector Analysis
Non-Small Cell Lung Cancer (NSCLC) – 5EU Drug Forecast and Market Analysis to 2025
Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung cancer incident cases, approximately 85% are the non-small cell lung cancer (NSCLC) subtype. NSCLC patients are usually diagnosed in the later stages of the disease, with poor prognosis. Historically, treatment options for advanced-stage NSCLC patients have been dominated by chemotherapy. However, the launch of targeted therapies such as Iressa (gefitinib) in 2003, Tarceva (erlotinib) in 2004, and Xalkori (crizotinib) in 2011, has shifted...
-
Sector Analysis
Non-Small Cell Lung Cancer (NSCLC) – Japan Drug Forecast and Market Analysis to 2025
Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung cancer incident cases, approximately 85% are the non-small cell lung cancer (NSCLC) subtype. NSCLC patients are usually diagnosed in the later stages of the disease, with poor prognosis. Historically, treatment options for advanced-stage NSCLC patients have been dominated by chemotherapy. However, the launch of targeted therapies such as Iressa (gefitinib) in 2003, Tarceva (erlotinib) in 2004, and Xalkori (crizotinib) in 2011, has shifted...
-
Sector Analysis
Non-Small Cell Lung Cancer (NSCLC) – China Drug Forecast and Market Analysis to 2025
Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung cancer incident cases, approximately 85% are the non-small cell lung cancer (NSCLC) subtype. NSCLC patients are usually diagnosed in the later stages of the disease, with poor prognosis. Historically, treatment options for advanced-stage NSCLC patients have been dominated by chemotherapy. However, the launch of targeted therapies such as Iressa (gefitinib) in 2003, Tarceva (erlotinib) in 2004, and Xalkori (crizotinib) in 2011, has shifted...
-
Sector Analysis
PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) – Global Drug Forecast and Market Analysis to 2025
Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung cancer incident cases, approximately 85% are the non-small cell lung cancer (NSCLC) subtype. NSCLC patients are usually diagnosed in the later stages of the disease, with poor prognosis. Historically, treatment options for advanced-stage NSCLC patients have been dominated by chemotherapy. However, the launch of targeted therapies such as Iressa (gefitinib) in 2003, Tarceva (erlotinib) in 2004, and Xalkori (crizotinib) in 2011, has shifted...
-
Sector Analysis
Health and Beauty Retailing in Belgium – Market Summary & Forecasts; Comprehensive overview of the market, consumer, and competitive context, with retail sales value and forecasts to 2020
The retail market for health and beauty products in Belgium reached EUR2.9 billion in 2015 and is forecast to grow at a CAGR of3.3% in 2015-2020, to reach EUR3.4 billion by 2020. Urbanization, increasing health consciousness, and a high percentage of obese population have fuelled the growth of the health and beauty category.